Among all PCa patients, 87% (34 out of 39) of the cases showed elevated levels of SREBP-2, with only 5 cases weakly expressing SREBP-2 (Figure 1A; Supplementary Table S1). Here, SREBF2 is linked to posterior cortical atrophy.